Literature DB >> 17881004

Fear responding to 35% CO(2) challenge as a vulnerability marker for later social anxiety symptoms.

Norman B Schmidt1, K R Timpano, Julia D Buckner.   

Abstract

The majority of biological challenge studies have focused on panic disorder though there is a small literature suggesting that patients with social anxiety disorder (SAD) show comparable responding. These cross-sectional studies suggest that CO(2) reactivity may be a marker of vulnerability to social anxiety. However, the nature of this association is unclear due to design limitations in this literature. The present report prospectively evaluated whether response to a 20% CO(2) challenge was predictive of later changes in social anxiety symptoms. A large non-clinical sample of young adults (N=404) screened for axis I disorders completed a 20% CO(2) challenge and were followed for approximately 18 months. Consistent with the vulnerability hypothesis, those showing greater reactivity to the CO(2) challenge showed increased social anxiety symptoms over time. This significant association was maintained after controlling for gender and trait anxiety. These data provide novel evidence suggesting that CO(2) sensitivity is predictive of the development of social anxiety symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881004      PMCID: PMC2453505          DOI: 10.1016/j.jpsychires.2007.08.005

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  26 in total

Review 1.  What can specificity designs say about causality in psychopathology research?

Authors:  J Garber; S D Hollon
Journal:  Psychol Bull       Date:  1991-07       Impact factor: 17.737

2.  High-dose carbon dioxide challenge test in anxiety disorder patients.

Authors:  J M Gorman; L A Papp; J Martinez; R R Goetz; E Hollander; M R Liebowitz; F Jordan
Journal:  Biol Psychiatry       Date:  1990-11-01       Impact factor: 13.382

3.  The 35% CO2 challenge test in patients with social phobia.

Authors:  D Caldirola; G Perna; C Arancio; A Bertani; L Bellodi
Journal:  Psychiatry Res       Date:  1997-06-16       Impact factor: 3.222

4.  The role of anxiety sensitivity in the pathogenesis of panic: prospective evaluation of spontaneous panic attacks during acute stress.

Authors:  N B Schmidt; D R Lerew; R J Jackson
Journal:  J Abnorm Psychol       Date:  1997-08

5.  Social anxiety symptoms uniquely predict fear responding to 35% CO(2) challenge.

Authors:  Norman B Schmidt; J Anthony Richey
Journal:  J Psychiatr Res       Date:  2007-11-05       Impact factor: 4.791

6.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

7.  Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorder.

Authors:  G Perna; S Cocchi; A Bertani; C Arancio; L Bellodi
Journal:  Am J Psychiatry       Date:  1995-04       Impact factor: 18.112

8.  Diagnostic and substance specificity of carbon-dioxide-induced panic.

Authors:  L A Papp; D F Klein; J Martinez; F Schneier; R Cole; M R Liebowitz; E Hollander; A J Fyer; F Jordan; J M Gorman
Journal:  Am J Psychiatry       Date:  1993-02       Impact factor: 18.112

9.  Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder.

Authors:  J M Gorman; L A Papp; J D Coplan; J M Martinez; S Lennon; R R Goetz; D Ross; D F Klein
Journal:  Am J Psychiatry       Date:  1994-04       Impact factor: 18.112

10.  Development and validation of measures of social phobia scrutiny fear and social interaction anxiety.

Authors:  R P Mattick; J C Clarke
Journal:  Behav Res Ther       Date:  1998-04
View more
  1 in total

1.  Clinical characteristics of latent classes of CO2 hypersensitivity in adolescents and young adults.

Authors:  Lance M Rappaport; Christina Sheerin; Jeanne E Savage; John M Hettema; Roxann Roberson-Nay
Journal:  Behav Res Ther       Date:  2017-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.